[1]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、 白介素-6的相关性研究[J].医学信息,2019,32(15):97-98,108.[doi:10.3969/j.issn.1006-1959.2019.15.030]
　XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Journal of Medical Information,2019,32(15):97-98,108.[doi:10.3969/j.issn.1006-1959.2019.15.030]
点击复制

老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、 白介素-6的相关性研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年15期
页码:
97-98,108
栏目:
临床研究
出版日期:
2019-08-01

文章信息/Info

Title:
Correlation between Mild Cognitive Impairment and Insulin Resistance and Interleukin-6 in Elderly Type 2 Diabetic Patients
文章编号:
1006-1959（2019）15-0097-03
作者:
谢小莉; 李 燕; 霍 敏; 毕立兵; 翟紫翔
宁夏银川市第二人民医院神经内科，宁夏 银川 750011
Author(s):
XIE Xiao-li; LI Yan; HUO Min; BI Li-bing; ZHAI Zi-xiang
Department of Neurology,Yinchuan Second People's Hospital,Yinchuan 750011,Ningxia,China
关键词:
2型糖尿病; 认知功能障碍; 胰岛素抵抗; 白介素-6
Keywords:
Key words：Type 2 diabetes; Cognitive dysfunction; Insulin resistance; Interleukin-6
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2019.15.030
文献标志码:
A
摘要:
目的 探讨老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、白介素-6的相关性。方法 选择我院2017年2月~2018年5月收治的老年2型糖尿病患者200例，根据是否存在轻度认知功能障碍分为观察组和对照组，各100例，所有患者进行空腹血糖（FBG）、空腹胰岛素（FINS）、白介素-6（IL-6）、糖化血红蛋白（HbA1c）、总胆固醇（TC）、甘油三脂（TG）、低密度脂蛋白胆固醇（LDL-C）测定，计算胰岛素抵抗指数（HOMA-IR），比较两组各指标差异，Logistic回归分析老年2型糖尿病患者认知障碍的影响因素。结果 观察组患者的FBG（8.72±0.36）mmol/L、FINS（11.46±3.45）μU/ml、IL-6（14.78±2.34）pg/ml、HbA1c（8.56±1.46）%、TC（6.76±1.31）mmol/L、HOMA-IR（5.15±1.62）均高于对照组的FBG（7.14±0.46）mmol/L、FINS（6.91±1.56）μU/ml、IL-6（6.92±1.54）pg/ml、HbA1c（7.91±1.75）%、TC（6.12±1.54）mmol/L、HOMA-IR（4.16±1.50），差异均有统计学意义（P＜0.05）；多因素Logistic回归分析显示，HOMA-IR、IL-6为老年2型糖尿病患者MCI发生的独立危险因素（P＜0.05）。结论 胰岛素抵抗、IL-6水平上升与老年2型糖尿病患者轻度MCI的发生存在相关性，可能是其主要危险因素，应早期干预。
Abstract:
Abstract：Objective To investigate the relationship between mild cognitive impairment and insulin resistance and interleukin-6 in elderly patients with type 2 diabetes.Methods We selected 200 elderly patients with type 2 diabetes admitted from February 2017 to May 2018 in our hospital. According to the presence or absence of mild cognitive impairment, we divided into observation group and control group, 100 cases each, and all patients underwent fasting blood glucose (FBG), fasting insulin (FINS), interleukin-6 (IL-6), glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) determination, calculation of insulin Resistance index (HOMA-IR), comparing the differences between the two groups, Logistic regression analysis of the influencing factors of cognitive impairment in elderly patients with type 2 diabetes.Results FBG (8.72±0.36) mmol/L, FINS (11.46±3.45) μU/ml, IL-6 (14.78±2.34) pg/ml, HbA1c (8.56±1.46)%, TC (6.76±1.31) mmol/L and HOMA-IR (5.15±1.62) in the observation group were higher than those of the control group (7.14±0.46) mmol/L, FINS (6.91±1.56) μU/ml, IL-6 (6.92±1.54) pg/ml, HbA1c (7.91±1.75)%, TC (6.12±1.54) mmol/L, HOMA-IR (4.16±1.50), the difference was statistically significant (P<0.05); multivariate logistic regression analysis HOMA-IR and IL-6 were independent risk factors for MCI in elderly patients with type 2 diabetes (P<0.05).Conclusion Insulin resistance and elevated IL-6 levels are associated with mild MCI in elderly patients with type 2 diabetes, which may be the main risk factors and should be intervened early.

参考文献/References:

[1]张璐,郭艺芳.2017年美国糖尿病学会糖尿病诊疗标准介绍[J].中华高血压杂志,2017,25(2):37-38. [2]谢燕,占克斌.糖尿病与认知障碍的相关研究[J].西南军医,2017,19(2):165-166. [3]董淑敏,孟庆阳,田立,等.2型糖尿病患者轻度认知功能障碍相关危险因素研究[J].现代医药卫生,2015,30(3):324-326. [4]常晓慧,周琳.2型糖尿病认知功能减退的研究现状[J].中华保健医学杂志,2015,17(1):65-67. [5]侯进义,孙菊光,史江峰,等.吡拉西坦联合盐酸多奈哌齐对血管性认知障碍病人血清TNF-α、IL-6、hs-CRP、Hcy水平的影响[J].中西医结合心脑血管病杂志,2018,16(7):954-958.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(15):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(15):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(15):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(15):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(15):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(15):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(15):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(15):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(15):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(15):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]

更新日期/Last Update: 2019-08-01